Table 2 shows that, as compared to patients not experiencing END, those at risk of END had significantly raised possibility of serum annexin A7 levels >57.4 ng/ml and extension of hematoma into intraventricular cavity, tended to display substantially increased NIHSS scores, hematoma volume, ICH scores, blood leucocyte count, blood glucose levels, and serum C-reactive protein levels, as well as exhibited markedly decreased GCS scores (all P < 0.05). This evidence concerns the gene ANXA7 and hematoma.